Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of…
| Price | $146.79 |
|---|---|
| Market cap | $362.54B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Exchange | NYSE |
| 52-week range | 77.58-156.92 |
| Dividend (TTM) | $3.40 per share |
| Beta | 0.23 |
Explore MRK's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.